Percutaneous absorption.
D000287:Administration, Topical; D000367:Age Factors; D000891:Anti-Infective Agents, Local / Q000378:metabolism; D000893:Anti-Inflammatory Agents / Q000378:metabolism; D046508:Culture Techniques; D003879:Dermatologic Agents / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005938:Glucocorticoids; D006493:Heparin / Q000378:metabolism; D006801:Humans; D008670:Metals / Q000378:metabolism; D008970:Molecular Weight; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D014677:Pharmaceutical Vehicles; D012039:Regional Blood Flow; D012459:Salicylates / Q000378:metabolism; D012867:Skin / Q000032:analysis / Q000098:blood supply / Q000293:injuries; D012869:Skin Absorption; D013499:Surface Properties; D013997:Time Factors; D014867:Water
D000891:Anti-Infective Agents, Local; D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D005938:Glucocorticoids; D008670:Metals; D004364:Pharmaceutical Preparations; D014677:Pharmaceutical Vehicles; D012459:Salicylates; D014867:Water; D006493:Heparin